Live

Hematological Malignancies

Oncology Solutions

In 2016, 467,000 new cases of leukemia and 310,000 deaths were reported. One in 118 men will develop the disease compared with one in 194 women. The main contributors to this increase were population growth with 12 percent, population aging with 10 percent, and an increase in age-specific incidence rates with 3 percent.1
In 2016, there were 461,000 incident cases of non-Hodgkin lymphoma and 240,000 worldwide, One in 110 men and one in 161 women developed non-Hodgkin lymphoma over a lifetime.1

The Patient Journey

  • Early Detection

    LOGIQ E10

    LOGIQ™ E10 Ultrasound

    Every day, you have the opportunity to make a real difference in the lives of your patients. We want to empower you to do just that with the LOGIQ E10 – by supporting your...
    PETCT-banner-Mobile

    PET/CT

    The true potential of PET/CT is its ability to enable a true discovery. A true discovery is...

  • Diagnosis

    Revolution CT

    Get uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution, temporal resolution and spectral imaging.
    PETCT-banner-Mobile

    PET/CT

    The true potential of PET/CT is its ability to enable a true discovery. A true discovery is...

  • Staging

    Computed Tomography

    Your need for quality patient care at low dose with greater productivity and affordability is more important than ever.  That’s why we design CT systems that...
    PETCT-banner-Mobile

    PET/CT

    The true potential of PET/CT is its ability to enable a true discovery. A true discovery is...

  • Treatment Planning

    LOGIQ E10

    LOGIQ™ E10 Ultrasound

    Every day, you have the opportunity to make a real difference in the lives of your patients. We want to empower you to do just that with the LOGIQ E10 – by supporting your...

    Revolution CT

    Get uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution, temporal resolution and spectral imaging.
  • Monitoring

    Revolution CT

    Get uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution, temporal resolution and spectral imaging.
    product-product-categories-pet-ct-qclear-gehc-qclear-qsuv_spotlight.jpg

    Q.Clear

    Pioneering PET image reconstruction technology, providing up to 2x improvement in image quality (SNR). It also delivers Q.SUV, quantitative SUV you and your patients can trust.
    PETCT-banner-Mobile

    PET/CT

    The true potential of PET/CT is its ability to enable a true discovery. A true discovery is...

  • Follow up

    LOGIQ E10

    LOGIQ™ E10 Ultrasound

    Every day, you have the opportunity to make a real difference in the lives of your patients. We want to empower you to do just that with the LOGIQ E10 – by supporting your...
    product-product-categories-pet-ct-qclear-gehc-qclear-qsuv_spotlight.jpg

    Q.Clear

    Pioneering PET image reconstruction technology, providing up to 2x improvement in image quality (SNR). It also delivers Q.SUV, quantitative SUV you and your patients can trust.
    ries-do-not-clone-advanced-visualization-applications-oncoquant-aw-oncoquant-spotlight-Listing

    OncoQuant

    Robust tools for routine Oncology diagnosis, treatment follow-up, reporting and clinical trial management.
    PETCT-banner-Mobile

    PET/CT

    The true potential of PET/CT is its ability to enable a true discovery. A true discovery is...

Live

The latest in Oncology


1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability,and Disability-Adjusted Life-Years for 29 Cancer Groups,1990 to 2016. A Systematic Analysis for the Global Burden of Disease Study. Christina Fitzmaurice,MD, MPH, Division of Hematology, Department of Medicine, Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Ave, Ste 600, Seattle,WA 98121